INCR — InterCure Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
- $44.84m
- $73.53m
- ILS270.20m
Annual cashflow statement for InterCure, fiscal year end - December 31st, ILS millions except per share, conversion factor applied.
C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.29 | 43.7 | -63.5 | -72.8 | -36.8 |
| Depreciation | |||||
| Non-Cash Items | 28.9 | 6.81 | 95.5 | 12.6 | 17.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -13.4 | -11 | -98.8 | -22.1 | 19.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 30.1 | 51.3 | -53.6 | -66.9 | 16.8 |
| Capital Expenditures | -14 | -19.7 | -2.62 | -4.83 | -3.55 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -51.2 | -123 | 7.39 | 22.5 | 1.56 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -65.2 | -142 | 4.77 | 17.7 | -1.99 |
| Financing Cash Flow Items | -5.12 | -17.3 | -20.9 | 18.7 | -19 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 198 | 120 | -82.9 | 26.5 | -46.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 158 | 36.4 | -131 | -22.8 | -31.9 |